kras mutation and glutathion glynac Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities potential therapeutic strategies Oncogenic Kras Maintains Pancreatic Tumors
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors Acetyl CoA metabolism in cancer PMC Pancreatic Cancer: Advances and Challenges PMC KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1 bioRxiv Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Metabolomics Springer Nature Link
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27





